Search Results - Holm, Clint A.

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Evaluation of physiological strain in hot work areas using thermal imagery

    Evaluation of physiological strain in hot work areas using thermal imagery by Holm, Clint A., Pahler, Leon, Thiese, Matthew S., Handy, Rodney

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Abstract 1545: Altered myeloid and lymphoid composition of tumor microenvironment following anti-SEMA4D and immune checkpoint combination therapies

    Abstract 1545: Altered myeloid and lymphoid composition of tumor microenvironment following anti-SEMA4D and immune checkpoint combination therapies by Evans, Elizabeth E., Fisher, Terrence L., Bussler, Holm, Mallow, Crystal, Reilly, Christine, Torno, Sebold, Pastore, Desa Rae, Scrivens, Maria, Howell, Alan, Balch, Leslie, Leonard, John E., Allen, Clint, Clavijo, Paul E., Lesinski, Gregory, Wu, Christina, Steuer, Conor, Saba, Nabil F., Olson, Brian, Hu-Lieskovan, Siwen, Ribas, Antoni, Greengard, Emily G., Smith, Ernest S., Zauderer, Maurice

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Abstract B199: Targeting the tumor microenvironment with first-in-class Semaphorin4D MAb for combination immunotherapy

    Abstract B199: Targeting the tumor microenvironment with first-in-class Semaphorin4D MAb for combination immunotherapy by Evans, Elizabeth E., Bussler, Holm, Mallow, Crystal, Reilly, Christine, Torno, Sebold, Scrivens, Maria, Foster, Cathie, Howell, Alan, Balch, Leslie, Leonard, John E., Fisher, Terrence L., Allen, Clint, Clavijo, Paul, Hu-Lieskovan, Siwen, Ribas, Antoni, Smith, Ernest S., Zauderer, Maurice

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 1762: Shifting the tumor microenvironment with first-in-class semaphorin 4D mab for combination immunotherapy

    Abstract 1762: Shifting the tumor microenvironment with first-in-class semaphorin 4D mab for combination immunotherapy by Evans, Elizabeth E., Bussler, Holm, Mallow, Crystal, Reilly, Christine, Torno, Sebold, Scrivens, Maria, Howell, Alan, Balch, Leslie, Leonard, John E., Fisher, Terrence, Allen, Clint, Clavijo, Paul E., Lesinski, Gregory, Wu, Christina, Hu-Lieskovan, Siwen, Ribas, Antoni, Greengard, Emily G., Smith, Ernest S., Zauderer, Maurice

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Abstract PR09: Breaking down barriers restricting myeloid cell differentiation and infiltration in the tumor microenvironment with a first-in-class antibody targeting semaphorin4D, and rational combination therapies

    Abstract PR09: Breaking down barriers restricting myeloid cell differentiation and infiltration in the tumor microenvironment with a first-in-class antibody targeting semaphorin4D,... by Evans, Elizabeth E., Bussler, Holm, Mallow, Crystal, Reilly, Christine, Torno, Sebold, Scrivens, Maria, Foster, Cathie, Howell, Alan, Balch, Leslie, Leonard, John E., Fisher, Terrence L., Allen, Clint, Clavijo, Paul, Hu-Leiskovan, Siwen, Ribas, Antoni, Smith, Ernest S., Zauderer, Maurice

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Abstract PR10: Reprogramming myeloid cells in TME with pepinemab, first-in-class semaphorin 4D MAb, enhances combination immunotherapy

    Abstract PR10: Reprogramming myeloid cells in TME with pepinemab, first-in-class semaphorin 4D MAb, enhances combination immunotherapy by Evans, Elizabeth E., Bussler, Holm, Mallow, Crystal, Reilly, Christine, Torno, Sebold, Scrivens, Maria, Howell, Alan, Balch, Leslie, Leonard, John E., Fisher, Terrence L., Allen, Clint, Clavijo, Paul, Lesiniski, Gregory, Wu, Christina, Hu-Lieskovan, Siwen, Ribas, Antoni, Greengard, Emily, Smith, Ernest S., Zauderer, Maurice

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: